INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03FWFogarty Patrick W0B / 60S60 trades$277K
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 32S32 trades$5.48M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,584 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
JC
Jope Alan C.Director
ACNAccenture plc
Tax withholding
F$672
3 sh
Feb 13, 2026Feb 17, 2026
Page 1302 of 1790
← PrevNext →
traded Feb 13, 2026
+4d
SEC Form 4

Evidence

9
UM
Uotani MasahikoDirector
ACNAccenture plc
Tax withholding
F$672
3 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MR
McPherson Danny REVP - Technology & CSO
VRSNVERISIGN INC/CA
Tax withholding
F$35K
159 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
RS
Reeder Raymond SeanCorporate Controller & CAO
ROGROGERS CORP
Tax withholding
F$5,713
53 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
OD
O'Leary-Gill DanielaDirector
MTGMGIC INVESTMENT CORP
Grant or award
A—
1 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M—
215 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M—
2,975 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Grant or award
A—
1,069 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
PA
Perry AndreDirector
MOFGMidWestOne Financial Group, Inc.
Disposition to issuer
D—
1,091 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
SB
Shah Mitesh BansilalSVP and CHRO
VMCVulcan Materials CO
Option exercise
M—
1,684 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BF
Baumgartner FlorianEVP and CEO, Vista
CMPRCIMPRESS plc
Option exercise
M—
1,691 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
BL
Boyd Tiffanie L.EVP - Chief People Officer
MCDMCDONALDS CORP
Grant or award
A—
22.1K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
409 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MG
McDonald GillianEVP, Global Rest. Exp. Ofc.
MCDMCDONALDS CORP
Option exercise
M—
2,231 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MG
McDonald GillianEVP, Global Rest. Exp. Ofc.
MCDMCDONALDS CORP
Option exercise
M—
161 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings John WChief Administrative Officer
TCBITEXAS CAPITAL BANCSHARES INC/TX
Option exercise
M—
1,470 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
38 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
JC
Jope Alan C.Director
ACNAccenture plc
Grant or award
A—
8 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
SB
Shah Mitesh BansilalSVP and CHRO
VMCVulcan Materials CO
Option exercise
M—
900 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BF
Baumgartner FlorianEVP and CEO, Vista
CMPRCIMPRESS plc
Option exercise
M—
1,303 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
NJ
Nason JenniferDirector
ACNAccenture plc
Tax withholding
F$448
2 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
UM
Uotani MasahikoDirector
ACNAccenture plc
Grant or award
A—
5 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BL
Boyd Tiffanie L.EVP - Chief People Officer
MCDMCDONALDS CORP
Option exercise
M—
70 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M—
290 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MM
Moore Susan MSVP, Chief Risk Officer
MOFGMidWestOne Financial Group, Inc.
Disposition to issuer
D—
1,353 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
1,879 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BP
Bhalla Narinder PalChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
297.0K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
31.2K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
38 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

8
PA
Patel AnishCHIEF OPERATING OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
20.0K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Tax withholding
F$100K
1,290 sh
Feb 14, 2026Feb 17, 2026
traded Feb 14, 2026
+3dSEC Form 4

Evidence

8
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
18.8K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
112.5K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
PA
Patel AnishCHIEF OPERATING OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
120.0K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

5
FM
Flatley Edith MorganEVP - Global CMO
MCDMCDONALDS CORP
Tax withholding · 10b5-1 plan
F$261K
798 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

5
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise
M—
250 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

5
MM
Macchi MauroChief Executive Officer-EMEA
ACNAccenture plc
Tax withholding
F$3,362
15 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

5
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Grant or award
A—
41 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

5
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$24K
50 sh
Feb 17, 2026Feb 17, 2026
traded Feb 17, 2026
+0dSEC Form 4

Evidence

5
MM
Macchi MauroChief Executive Officer-EMEA
ACNAccenture plc
Grant or award
A—
27 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence